EP262

· Escient Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for EP262, covering 2024-12-09 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria [Phase 2]

See pricing